ArticleHaematologica2026

Interleukin signaling mitigates the inhibitory effects of combined Src/BCR-ABL1 blockade on T-cell activity in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Farnaz Naeemikia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.